Breast lump is one of the commonest presentations of breast diseases. The diagnosis of breast diseases can be achieved like in other clinical conditions using: history, physical examination and investigation which include cytological or histological confirmation. Currently, several studies have advocated the use of 'Triple test' which consists of clinical examination, radiologic examination and cytopathology as more accurate means of making diagnosis of breast lesions (1-5). When all the three components are positive, diagnostic accuracy approaches 100% for malignancy (2). Fine Needle Aspiration cytology (FNAC) is widely used and accepted as a reliable method of making initial pre-operative diagnosis in breast diseases (2, 6). It has been credited with a lot of advantages such as: high accuracy, cheap, fast, out-patient procedure reducing pressure on theatre load, high patient acceptability, and low complication rate (2, 6).
Materials and Methods
This is a one-year prospective study of all the consecutive patients with palpable breast lesion presenting at the two general surgery out-patient clinics of the University Teaching Hospital. Approval was sought from the Ethical committee of the University Teaching Hospital before the commencement of the study. The procedure was duly explained to the patients, and that the lump will be removed for histology after the FNAC. Their informed written consent was obtained. Patients who had FNAC were followed up until the histology report was obtained following open surgical biopsy.
Patient lies supine on a couch after exposure of the upper half of the body. The surgeon after washing hands with soap and water wears a pair of surgical gloves. The skin of the breast over the lump was disinfected using gauze soaked in 75% methylated spirit. The dominant hand was used to handle the syringe with 25G needle in place. The other hand was used to stabilize the tumour within the breast. The needle on the syringe was then advanced into the tumour and negative pressure was generated by pulling on the plunger and maintaining the pressure with the fingers and thumb. The needle was moved in and out in different directions in the tumour while maintaining the negative pressure. The movement of the needle continues until adequate material appears in the hub of the needle. The negative pressure was released and the needle withdrawn from the breast. The syringe was separated from the needle, filled with air, re-attached to the needle and its content expressed onto the centre of the microscope slides (wet and dry). Smears were made by spreading the aspirate using another clean slide placed at 45 degree and running it over the slide. The wet slide was fixed by putting it into a Coplin jar containing 95% ethanol while the dry slide was fixed by air-drying (for at least 5 minutes). The two groups of slides were then transported to the laboratory for staining and cytology reporting. If material aspirated was insufficient, further needle passes were done. If the lump is cystic, the entire cyst was completely aspirated, labelled and sent to laboratory for centrifuging and further processing. Residual masses after cyst aspiration were handled like other solid masses.
The wet slides were stained with Papanicolaou staining technique while the dry slides were stained using May-Grunwald-Giemsa staining technique. The patients were also worked up for open surgical biopsies and the samples collected from each patient was immersed in a container with 10% formalin and transported to the histopathology laboratory for preparation and reading.
The cytology and histology reports were documented in the pro-forma used for the study when they were ready. The cytological diagnoses were categorized into one of the five diagnostic categories according to the recommendations of the United Kingdom National Health Services Breast Screening Programme (NHSBSP) (7) . The breast samples from FNAC were further sub-classified into definite breast disease entities. The final histopathological diagnosis of each case was then compared with the cytological diagnosis. 
Results
A total of 180 patients were enrolled into the study. All had clinical evaluation as well as FNAC. Only 113 patients had open biopsy with Histology report. Sixty-seven patients defaulted from open surgical biopsy due to one reason or another. The above finding gives a biopsy rate of 63% and default rate of 37%. Only patients who had open biopsy with histology reports were further evaluated. Out of the 113 patients with histology report, two showed normal breast tissues and another one, inadequate specimen. Of the two cases of normal histology, one was C4 and the other C1 on FNAC while the case with inadequate specimen on histology was C5 on FNAC. The three were further excluded leaving only 110 patients who were used in the comparative aspect of the study, and to test validity.
Thirty-eight (34.6%) smears were unequivocally malignant (C5) while 46 (41.8%) were benign (C2) i.e. negative for malignant cells. Five (4.5%) smears were probably benign (C3) while 4 (3.6%) smears were suspicious for malignancy (C4). Seventeen (15.5%) smears were unsatisfactory/inadequate (C1) giving an unsatisfactory rate of 15.5%.
Out of the 38 cases that were positive for malignancy on cytology, 36 of them were true positive and two were false positive. Out of 46 cases that were benign on cytology, 42 were true negative while four were false negative. Out of the 17 unsatisfactory cases on cytology, nine were benign on histology while eight were malignant. Three out of the five cases that were probably benign on cytology were confirmed benign on histology while two were confirmed malignant. Out of the four cases suspicious for malignancy on cytology, two were benign on histology while two were confirmed malignant (Table1).
Diagnostic validities of FNAC when both unsatisfactory and suspicious smears are excluded is shown in Table 2 .
195 Only 86 (78.2%) of the 110 smears could be sub-classified into different disease conditions of the breast on cytology. Twenty-four (21.8%) smears could not be sub-classified. Out of the 86 smears sub-classified, fibroadenoma was 32 in number and invasive ductal carcinoma was also 32 in number. The rest of the sub-classes are shown below (Table 3) .
Out of the 32 diagnosis of fibroadenoma on FNAC, histology confirmed: 25 (78.1%) to be fibroadenoma, five (15.6%) to be fibrocystic changes and one (3.1%) each of invasive ductal carcinoma and mastitis. Also, out of another 32 diagnosis of invasive ductal carcinoma by FNAC, histology confirmed: 28 (87.5%) of them to be invasive ductal carcinoma and the remaining 4 (12.5%) to be metaplastic carcinoma.
Discussion
Fine needle aspiration cytology (FNAC) was found to be more specific than sensitive in this study, 95.5% and 90.0%, respectively with overall diagnostic accuracy of 92.9% (Table 2) . These values are comparable to those documented in similar studies (10) (11) (12) (13) (14) and much higher than >60% for specificity and > 80% for sensitivity recommended by NHSBSP of Britain (7). The high values for sensitivity, specificity and overall diagnostic accuracy obtained in this study may be due to the fact that only palpable lumps were sampled and the fact that most of the patients presented late with large lumps. With sensitivity of 90.0% in this study, it means that the diagnosis of malignancy can be made about 90% of the times by FNAC. Also with specificity of 95.5% obtained in this study, it means that FNAC can exclude malignancy in about 95.5% of the cases. And with overall diagnostic accuracy of 92.9%, it shows that FNAC can make diagnosis of both benign and malignant diseases in about 92.9% of the cases.
Apart from telling whether a lesion is benign or malignant, FNAC can significantly sub-classify breast lesions into definite histological entities. According to the study by Young et al (8) , FNAC of the breast is a reliable method for the diagnosis of breast carcinoma but difficulties still exist in their ability to determine tumour sub-type. In the above study, performance was best for the diagnosis of adenocarcinoma (ductal type) with 65% accuracy. The rates for exact diagnosis of lobular, medullary and mucinous carcinomas were 20%, 12%, and 27%, respectively.
In the current study, only 86 (78.2%) of the 110 smears could be sub-classified into different histological conditions of the breast on cytology. Twenty-four (21.8%) smears could not be sub-classified. Out of the 86 smears sub-classified by FNAC, fibroadenoma was 32 in number and invasive ductal carcinoma was also 32 in number. Correlation of FNAC sub-classification with histopathology results showed that: out of the 32 diagnoses of fibroadenoma on FNAC, histology confirmed: 25 to be fibroadenoma giving an accuracy of 78.1%, five to be fibrocystic changes and one each of invasive ductal carcinoma and mastitis. Also, out of another 32 diagnoses of invasive ductal carcinoma by FNAC, histopathology confirmed: 28 of them to be invasive ductal carcinoma with an accuracy of 87.5% and the remaining four to be metaplastic carcinoma. Three diagnoses of metaplastic carcinoma on FNAC proved to be two invasive ductal carcinomas and one metaplastic carcinoma on histopathology. Also, a diagnosis of papillary carcinoma on FNAC was confirmed invasive ductal carcinoma on histopathology. One diagnosis of lobular carcinoma on FNAC proved to be mastitis on histopathology. Two cases of mastitis on FNAC were accurately diagnosed as mastitis on histopathology. Also, out of the eight cases of fibrocystic changes by FNAC, four were fibrocystic changes while three were invasive ductal carcinoma and one adenosis on histopathology ( Table 3 ).
The accuracy of FNAC in this study to sub-classify breast diseases was comparable to that by Young et al (8) in their study on diagnosis and sub-classification of breast carcinoma by FNAC. The current study however achieved higher accuracy of 87.5% compared to 65% by Young et al (8) for invasive ductal carcinoma. However, making accurate diagnosis of metaplastic carcinoma, papillary carcinoma, lobular carcinoma and fibrocystic changes is still a problem. Maygarden et al (9) in their study on sub-classification of benign breast disease by fine needle aspiration cytology, comparing cytological and histopathological findings in 265 palpable breast masses found that overall, the specific diagnosis was correct in 80% of cases. This is comparable to the accuracy of 78.1% for fibroadenoma obtained in the current study. Also, in another study by López-Ferrer et al (15) on Fine needle aspiration cytology of breast fibroadenoma, correlating the cytopathology and histopathology of 405 cases, cytohistological agreement was present in 287 of the 362 cytodiagnoses. This ensured the sensitivity of the cytological diagnosis of Fibroadenoma to be 86.9% with a positive predictive value of 79.3%. This is slightly higher than the value obtained in this present study.
Only 113 of 180 patients initially recruited for the study presented for open surgical biopsy and histopathology. Sixty-seven patients defaulted for some reasons and that formed a major limitation for the study.
Conclusion
Fine needle aspiration cytology can reasonably sub-classify fibroadenoma, invasive ductal carcinoma and mastitis but there is still a challenge with lobular carcinoma, metaplastic carcinoma, papillary carcinoma and fibrocystic changes.
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